GC Biopharma Dividend

Dividend criteria checks 1/6

GC Biopharma is a dividend paying company with a current yield of 1.31%.

Key information

1.3%

Dividend yield

500%

Payout ratio

Industry average yield0.5%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Earnings per share-₩2.33k
Dividend yield forecast in 3Y1.3%

Recent dividend updates

Recent updates

GC Biopharma Corp.'s (KRX:006280) Business And Shares Still Trailing The Industry

Mar 08
GC Biopharma Corp.'s (KRX:006280) Business And Shares Still Trailing The Industry

We Think Green Cross (KRX:006280) Can Stay On Top Of Its Debt

May 02
We Think Green Cross (KRX:006280) Can Stay On Top Of Its Debt

Are Green Cross Corporation's (KRX:006280) Mixed Financials Driving The Negative Sentiment?

Mar 10
Are Green Cross Corporation's (KRX:006280) Mixed Financials Driving The Negative Sentiment?

Shareholders Are Thrilled That The Green Cross (KRX:006280) Share Price Increased 268%

Feb 18
Shareholders Are Thrilled That The Green Cross (KRX:006280) Share Price Increased 268%

Green Cross (KRX:006280) Has A Somewhat Strained Balance Sheet

Jan 31
Green Cross (KRX:006280) Has A Somewhat Strained Balance Sheet

Calculating The Intrinsic Value Of Green Cross Corporation (KRX:006280)

Jan 14
Calculating The Intrinsic Value Of Green Cross Corporation (KRX:006280)

What You Need To Know About Green Cross Corporation's (KRX:006280) Investor Composition

Dec 27
What You Need To Know About Green Cross Corporation's (KRX:006280) Investor Composition

Green Cross Corporation's (KRX:006280) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Dec 09
Green Cross Corporation's (KRX:006280) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Does Green Cross's (KRX:006280) Statutory Profit Adequately Reflect Its Underlying Profit?

Nov 21
Does Green Cross's (KRX:006280) Statutory Profit Adequately Reflect Its Underlying Profit?

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Whilst dividend payments have been stable, A006280 has been paying a dividend for less than 10 years.

Growing Dividend: A006280 has only been paying a dividend for 7 years, and since then payments have fallen.


Dividend Yield vs Market

GC Biopharma Dividend Yield vs Market
How does A006280 dividend yield compare to the market?
SegmentDividend Yield
Company (A006280)1.3%
Market Bottom 25% (KR)1.0%
Market Top 25% (KR)3.5%
Industry Average (Biotechs)0.5%
Analyst forecast in 3 Years (A006280)1.3%

Notable Dividend: A006280's dividend (1.31%) is higher than the bottom 25% of dividend payers in the KR market (1%).

High Dividend: A006280's dividend (1.31%) is low compared to the top 25% of dividend payers in the KR market (3.54%).


Earnings Payout to Shareholders

Earnings Coverage: With its high payout ratio (500.2%), A006280's dividend payments are not well covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: A006280 is paying a dividend but the company has no free cash flows.


Discover strong dividend paying companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.